Lechenie sakharnogo diabeta 2 tipa ingibitorami dipeptidilpeptidazy-4
Type 2 diabetes is difficult to manage and multiple therapeutic approach are usually needed. Moreover, addition to the initial treatment of most currently available oral antidiabetic agents increases the risk of hypoglycaemia and causes a weight gain. Dipeptidyl peptidase-IV inhibitors improve glyca...
Enregistré dans:
| Format: | Artigo |
|---|---|
| Langue: | Inglês |
| Publié: |
Endocrinology Research Centre
2010-09-01
|
| Collection: | Ожирение и метаболизм |
| Sujets: | |
| Accès en ligne: | https://www.omet-endojournals.ru/jour/article/view/4976 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
